| 摘要 |
FIELD: medicine; pharmaceuticals.SUBSTANCE: group of inventions relates treating bacterial infections. Disclosed is a antibacterial combination containing (a) at least one antibacterial agent selected from cefepime, cefpirome, or salts thereof; and (b) tazobactam or salt thereof; said combination is further characterised by that it contains: (i) 1 g of antibacterial agent and 1 g tazobactam; or (ii) 2 g antibacterial agent and 2 g tazobactam; or (iii) 0.5 g antibacterial agent and 0.5 g tazobactam (versions). Disclosed is use of disclosed versions of antibacterial combination for treating or controlling a bacterial infection in a patient (versions).EFFECT: technical result consists in synergetic antibacterial action and efficiency against bacterial infection caused by highly resistant strains, forming a beta-lactamase in a wide range.15 cl, 7 tbl |
